Switzerland· 62812001

Votubia 2 mg, dispergierbare Tabletten

A everolimus product containing everolimusum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01XE10

Checked against Swissmedic (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about everolimusumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Everolimus is registered in 3 of 19 countries.

Countries holding a registration under ATC L01XE10 (everolimus), each read from that country’s own register.

This record: Switzerland, from Swissmedic (Switzerland)
2 of them publish a price we can compare per daily dose

Search everolimus products by name

Everolimus · ATC L01XE10

3 / 19 countries

Ireland
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)

Active substance: everolimusum
Manufacturer: Novartis Pharma Schweiz AG
Country: Switzerland (CH)
ATC code: L01XE10
ATC class: Everolimus
Swissmedic category: A
Reimbursed: Yes
Source register: Swissmedic (Switzerland)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

gtin
7680628120019
30 Stk
CHF 1007.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

430 interactions on record for everolimus.

Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check everolimus against other medicines How interaction checks work

Everolimus · interactions on record

430 records

165 severe
255 moderate
8 minor

Most severe, free to view

AprepitantA04AD12severe
NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Everolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All everolimus products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

Austria · Certican, Everolimus Ethypharm
Belgium · Certican, Everolimus Eg
Bulgaria · Еверолимус Крка, Еверолимус Майлан
Cyprus · Certican, Everolimus Pharmazac
Czechia · Certican, Everolimus Accord
Germany · Certican, Everofin
Denmark · Certican, Everolimus Krka
Estonia · Certican, Everolimus Krka
Spain · Certican, Everolimus Accord
Finland · Aderolio, Certican
France · Certican, Everolimus Arrow
United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
Greece · Certican, Everolimus Faran
Croatia · Certican, Everolimus Krka
Hungary · Certican, Everolimus Accord
Ireland · Certican, Everolimus Tad
Iceland · Afinitor, Certican
Italy · Certican, Everolimus Accord
Liechtenstein · Afinitor, Votubia
Lithuania · Certican, Everolimus Norameda
Luxembourg · Certican, Everolimus Eg
Latvia · Certican, Everolimus Norameda
Malta · Certican, Everolimus Ascend
Netherlands · Certican, Certican Dispers
Norway · Afinitor, Certican
Poland · Aderolio, Certican
Portugal · Certican, Everolimus Ethypharm
Romania · Certican, Everolimus Accord
Sweden · Certican, Everolimus Avansor
Slovenia · Certican, Everolimus Krka
Slovakia · Certican, Everolimus Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9ad1f3a1-2b92-423d-a4c6-c55f9b36e947
GET /v1/drugs/9ad1f3a1-2b92-423d-a4c6-c55f9b36e947?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "everolimusum 2 mg",
  "valid_from": "2014-06-01",
  "limitations": "[{\"description\":\"Bei Patienten mit Tuberöser Sklerose:<br>\\n- Zur Behandlung vom subependymalen Riesenzellastrozytom (SEGA), wenn eine chirurgische Behandlung nicht angemessen ist.<br>\\n<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2020-12-01\"}]",
  "galenic_form": "Disp Tabl 2 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2014-06-01",
  "self_retention_pct": 10
}

API reference MCP server Plans

See everything about everolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console